IMARC Group has recently released a new research study titled “Mexico Home Infusion Therapy Market Size, Share, Trends and Forecast by Product, Application, and Region, 2025-2033” which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

Market Overview

The Mexico home infusion therapy market size reached USD 544.80 Million in 2024 and is expected to grow to USD 957.40 Million by 2033. The market is projected to expand at a CAGR of 5.80% during the forecast period from 2025 to 2033. Growth is driven by the increasing prevalence of chronic diseases, sensitivity to healthcare costs, demand for home-based medical care, and advancements in infusion device technology and healthcare infrastructure. Greater insurance coverage and specialist support further enhance patient access.

Study Assumption Years

  • Base Year: 2024

  • Historical Years: 2019-2024

  • Forecast Year/Period: 2025-2033

Mexico Home Infusion Therapy Market Key Takeaways

  • Current Market Size: USD 544.80 Million in 2024

  • CAGR: 5.80% (2025-2033)

  • Forecast Period: 2025-2033

  • Mexico is experiencing a steady increase in chronic illnesses such as cancer, diabetes, and autoimmune diseases, boosting the demand for home infusion therapies.

  • Rising elderly population requiring regular infusion-based care supports market growth.

  • Technological advancements in infusion pumps and supportive healthcare infrastructure are facilitating market expansion.

  • Enhanced insurance coverage and specialist support improve patient access to home infusion therapy.

  • Cancer patients, diabetics, and individuals with immune deficiencies increasingly prefer home-based care for comfort and convenience.

Sample Request Link: https://www.imarcgroup.com/mexico-home-infusion-therapy-market/requestsample

Mexico Home Infusion Therapy Market Growth Factors

The market for home infusion therapy in Mexico is propelled significantly by a rising incidence of chronic diseases. The report highlights that cancer, diabetes, and autoimmune diseases demand intricate and continuous medical treatment regimes. Data from OECD projects that cancer will cause 46,200 premature deaths annually in Mexico and by 2050 is expected to contribute to one in 14 deaths before age 75, negatively impacting life expectancy by 0.9 years and resulting in notable healthcare cost increases of MXN 10.6 billion. This chronic disease burden drives preference for home infusion therapy from traditional hospital-based care, enabling more flexible scheduling and reduced infection risks.

Another key driver is the country’s growing elderly population which accounted for 8.2% of the population in 2024, increasing 3.2 percentage points since 2000. The aging populace faces chronic conditions like cardiovascular diseases, arthritis, cancer, and diabetes, necessitating regular infusion therapies that can be challenging with frequent hospital visits. Home infusion therapy meets this demand by delivering hydration, antibiotics, pain management, and nutritional support directly in patients’ homes, enhancing quality of life and reducing hospital-acquired infection risks and costs.

Technological improvements in infusion devices including elastomeric, electromechanical, and gravity pumps, as well as enhanced healthcare infrastructure, catalyze market growth. Additionally, broadened insurance coverage and specialist healthcare support facilitate easier patient access to home infusion therapy, making this treatment mode increasingly preferred. These factors collectively fuel the market’s expansion during the 2025-2033 forecast period.

Mexico Home Infusion Therapy Market Segmentation

Product Insights:

  • Infusion Pumps: Elastomeric, Electromechanical, Gravity, Others

  • Intravenous Sets

  • IV Cannulas

  • Needleless Connectors

Each product segment covers devices and consumables critical to home infusion therapy administration, including various types of infusion pumps and associated intravenous accessories.

Application Insights:

  • Anti-Infective

  • Endocrinology: Diabetes, Others

  • Hydration Therapy: Athletes, Others

  • Chemotherapy

  • Enteral Nutrition

  • Parenteral Nutrition

  • Specialty Pharmaceuticals

  • Others

Applications encompass a broad range of therapeutic areas requiring infusion therapy at home, including infection control, diabetes management, nutrition, cancer treatment, and specialty drugs.

Regional Insights:

  • Northern Mexico

  • Central Mexico

  • Southern Mexico

  • Others

The market is segmented regionally to capture demand variations across the major geographic areas within Mexico.

Regional Insights

Northern Mexico, Central Mexico, Southern Mexico, and other regions constitute the primary areas of market activity. The report details comprehensive analyses of these regions but does not specify a dominant region or precise market shares. The segmentation ensures regional demand and development opportunities are identified and leveraged to propel overall market growth.

Speak to an Analyst: https://www.imarcgroup.com/request?type=report&id=33986&flag=C

Competitive Landscape

The market research report covers a comprehensive competitive landscape analysis including market structure, key player positioning, winning strategies, competitive dashboards, and company evaluation quadrants. Detailed profiles of all major companies have been provided.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302